Biology Reference
In-Depth Information
91. Haller J, Hyde D, Deliolanis N, de Kleine R, Niedre M, Ntziachristos V. Visualization
of pulmonary inflammation using noninvasive fluorescence molecular imaging.
J Appl
Physiol
2008;
104
:795-802.
92. von Burstin J, Eser S, Seidler B, Meining A, Bajbouj M, Mages J, et al. Highly sensitive
detection of early-stage pancreatic cancer by multimodal near-infrared molecular im-
aging in living mice.
Int J Cancer
2008;
123
:2138-47.
93. Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM. Optical imaging of matrix
metalloproteinase-7 activity in vivo using a proteolytic nanobeacon.
Mol Imaging
2008;
7
:118-31.
94. Sheth RA, Upadhyay R, Stangenberg L, Sheth R, Weissleder R, Mahmood U.
Improved detection of ovarian cancer metastases by intraoperative quantitative fluores-
cence protease imaging in a pre-clinical model.
Gynecol Oncol
2009;
112
:616-22.
95. Klohs J, Baeva N, Steinbrink J, Bourayou R, Boettcher C, Royl G, et al. In vivo near-
infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ische-
mia.
J Cereb Blood Flow Metab
2009;
29
:1284-92.
96. Ignat M, Aprahamian M, Lindner V, Altmeyer A, Perretta S, Dallemagne B, et al. Fea-
sibility and reliability of pancreatic cancer staging using fiberoptic confocal fluorescence
microscopy in rats.
Gastroenterology
2009;
: 1584-92 e1.
97. Nahrendorf M, Waterman P, Thurber G, Groves K, Rajopadhye M, Panizzi P, et al.
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with custom-
ized nanosensors.
Arterioscler Thromb Vasc Biol
2009;
29
:1444-51.
98. Habibollahi P, Figueiredo JL, Heidari P, Dulak AM, Imamura Y, Bass AJ, et al. Optical
Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal
Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy.
Theranostics
2012;
2
:227-34.
99. Tung CH, Bredow S, Mahmood U, Weissleder R. Preparation of a cathepsin D sen-
sitive near-infrared fluorescence probe for imaging.
Bioconjug Chem
1999;
10
:892-6.
100. Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, et al. Cathepsin B and
tumor proteolysis: contribution of the tumor microenvironment.
Semin Cancer Biol
2005;
15
:149-57.
101. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association
between myeloperoxidase levels and risk of coronary artery disease.
137
JAMA
2001;
286
:2136-42.
102. Kedem O, Katchalsky A. Thermodynamic analysis of the permeability of biological
membranes to non-electrolytes.
Biochim Biophys Acta
1958;
27
:229-46.
103. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vas-
cular permeability, accumulation, and penetration of macromolecular drug carriers.
J Natl Cancer Inst
2006;
98
:335-44.
104. Qin S, Seo JW, Zhang H, Qi J, Curry FR, Ferrara KW. An imaging-driven model for
liposomal stability and circulation.
Mol Pharm
2010;
7
:12-21.
105. Kim J, YuW, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell
intravasation as
semiquantitative PCR-based assay.
Cell
revealed by a novel
1998;
94
:353-62.
106. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors
to tumor progression.
Mol Med Today
2000;
:149-56.
107. Gherardi E, Birchmeier W, Birchmeier C, Vande Woude G. Targeting MET in can-
cer: rationale and progress.
Nat Rev Cancer
2012;
12
:89-103.
108. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the
extracellular matrix during invasion and metastasis.
Annu Rev Cell Biol
1993;
9
:541-73.
109. Bogdanov Jr. AA, Lin CP, Simonova M, Matuszewski L, Weissleder R. Cellular ac-
tivation of the self-quenched fluorescent reporter probe in tumor microenvironment.
Neoplasia
2002;
4
:228-36.
6
Search WWH ::
Custom Search